Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:1785 |
| Name | pituitary cancer |
| Definition | An endocrine gland cancer located_in the pituitary gland located at the base of the brain. |
| Source | DiseaseOntology.org |
| Alt Ids | DOID:5671 |
| Path | disease disease of cellular proliferation cancer organ system cancer endocrine gland cancer pituitary cancer |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT00939523 | Phase II | Lapatinib | Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy | Completed | USA | 0 |
| NCT04042753 | Phase II | Ipilimumab + Nivolumab Nivolumab | Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors | Active, not recruiting | USA | 0 |
| NCT04106843 | Phase II | Lutetium Lu 177 dotatate | Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers | Withdrawn | USA | 0 |